Instil Bio, Inc.
TIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789769
No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Instil Bio, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 38 | 34 | −4 |
| Shares | 4.65M | 4.55M | −96.0K (−2.1%) |
| Value | $96.9M | $81.3M | −$15.5M (−16.0%) |
New holders (5)
Institutions that held Instil Bio, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 44,878 | $801.5K | 0.00% |
| LPL Financial LLC | 33,687 | $601.6K | 0.00% |
| Jane Street Group, LLC | 20,802 | $371.5K | 0.00% |
| Farther Finance Advisors, LLC | 111 | $1.98K | 0.00% |
| SBI Securities Co., Ltd. | 1 | $18 | 0.00% |
Sold out (9)
Institutions that held Instil Bio, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Goldman Sachs Group Inc | 163,261 | $3.40M |
| Balyasny Asset Management LLC | 88,796 | $1.85M |
| Renaissance Technologies LLC | 70,655 | $1.47M |
| Assenagon Asset Management S.A. | 57,497 | $1.20M |
| Trexquant Investment LP | 17,369 | $361.8K |
| Exome Asset Management LLC | 16,200 | $337.4K |
| GF Fund Management Co. Ltd. | 3,000 | $62.5K |
| Raymond James Financial Inc | 1,433 | $29.9K |
| Eq Wealth Advisors, LLC | 40 | $833 |